MichaelKuettelMD MBA, PhD, FACR, FACRO, FASTRO

Radiation Oncology • Buffalo, NY

Urologic Cancer

Professor of Radiation Oncology, SUNY Buffalo

Join to view full profile

Dr. Kuettel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kuettel's full profile

Already have an account?

Office
Elm and Carlton St
Buffalo, NY 14263
Phone+1 716-845-2300

Fax+1 716-845-8254

Education & Training

Johns Hopkins UniversityResidency, Radiation Oncology, 1987 - 1990
McGaw Medical Center of Northwestern UniversityInternship, Internal Medicine, 1985 - 1986
Northwestern University The Feinberg School of MedicineClass of 1985

Certifications & Licensure

NY State Medical License 1999 - 2026
DC State Medical License 1990 - 2000
MD State Medical License 1987 - 2000
VA State Medical License 1996 - 2000
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Buffalo Spree Magazine Castle Connolly, 2005-2021
America's Top Doctors Castle Connolly, 2005-2021
America's Top Doctors for Cancer Castle Connolly, 2005-2021

Clinical Trials

Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate Cancer Start of enrollment: 2005 Mar 01
Completed
Phase 1
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2009 Sep 01
Active, not recruiting
Phase 3

Publications & Presentations

PubMed

1 citations
Phase II Trial of Concurrent Nivolumab and Radiation Therapy for Muscle-Invasive Bladder Cancer of Older or Chemotherapy-Ineligible Patients.
Ulka N Vaishampayan, Lance Heilbrun, Nitin Vaishampayan, Felicity W K Harper, Dongping Shi
International Journal of Radiation Oncology, Biology, Physics. 2024-04-01
24 citations
NCCN Guidelines® Insights: Prostate Cancer, Version 3.2024.
Edward M Schaeffer, Sandy Srinivas, Nabil Adra, Yi An, Rhonda Bitting
Journal of the National Comprehensive Cancer Network. 2024-04-01
The impact of NCCN-compliant multidisciplinary conference on the uptake of active surveillance among eligible patients with localized prostate cancer.
Ahmed A Hussein, Usma Shabir, Abdul Wasay Mahmood, Grace Harrington, Mohammad Khan
Urologic Oncology. 2023-12-01

Press Mentions

Annual Report 2023 - American Society for Radiation OncologySeptember 16th, 2024
Multidisciplinary Review Panel Shown to Move Treatment Recommendations Toward Best PracticesApril 14th, 2023
Shop TalkOctober 5th, 2020
Join now to see all